PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
March 10, 2026CNS Neuroscience & Therapeutics0 citationsOpen Access

SMPD1 as a Potential Prognostic Biomarker in Glioma Is Associated With an Immunosuppressive Microenvironment

View Full Paper
YXYanan XuXLXia LiuBXBoya Xu

Key Points

  • This research aims to evaluate SMPD1 as a prognostic biomarker and its role in creating an immunosuppressive environment in gliomas.
  • Assessment of SMPD1 expression levels in glioma samples
  • Analysis of the relationship between SMPD1 and tumor microenvironment characteristics
  • Evaluation of the implications for glioma immunotherapy
  • SMPD1 is significantly upregulated in glioma tissues
  • Higher SMPD1 levels correlate with an immunosuppressive microenvironment
  • SMPD1's expression may promote tumor progression and affect treatment responses

Abstract

SMPD1 is a potential biomarker and therapeutic target in gliomas. Its upregulation may contribute to the formation of an immunosuppressive microenvironment and promote tumor progression, highlighting its potential relevance in glioma immunotherapy.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Xu et al. (2026) studied this question.

synapsesocial.com/papers/69af959570916d39fea4d5b4https://doi.org/10.1002/cns.70813
Ask AI
Helpful
Bookmark
Share
View Full Paper